Actuate Therapeutics IncACTUNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-1.01%
↑ 87% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-7.51%
Historical baseline
PeriodValue
2024-1.01%
2023-21.53%
20220.00%